Three Years of Daily BCI Use Turns ALS Patient Into a Stress Test for Speech Implants
Casey Harrell's near-three-year BCI run is the longest real-world speech-restoration trial yet, raising the stakes for Neuralink and Synchron.
6. Three Years of Daily BCI Use Turns ALS Patient Into a Stress Test for Speech Implants
Casey Harrell, a man with ALS who is fully paralyzed, has been using a brain-computer interface to produce speech for nearly three years, making him the longest-running real-world power user of speech-restoration BCI technology on record. Electrodes embedded in his brain first allowed him to generate sentences with research team support in 2023. Since then, Harrell has accumulated thousands of hours of independent use, far beyond the short clinical windows that most BCI trials report. The work is affiliated with researchers at UC San Francisco, the same group behind earlier high-profile BCI speech milestones.
The duration matters competitively. Neuralink's first human implant, reported in early 2024, and Synchron's Stentrode trials have both generated strong early data, but neither has produced a comparable longitudinal record in a speech-restoration context. Thousands of hours of continuous use is a different category of evidence than peak-session benchmarks. It surfaces signal degradation, electrode stability, software reliability, and user adaptation in ways that short trials cannot. Any company claiming clinical readiness for a speech BCI now has to account for what a multi-year daily-use profile looks like, and Harrell's case sets that bar concretely for the first time.
The broader pattern here is that the BCI field is quietly moving from proof-of-concept demonstrations to durability questions. Regulators at the FDA have been watching implant longevity closely as the agency weighs expanded approval pathways. What Harrell's case introduces is the first sustained real-world argument that speech BCIs can hold up outside controlled lab sessions. The next data point to watch is whether UCSF's team publishes longitudinal electrode performance metrics, and whether Synchron or Neuralink respond with comparable long-term usage records from their own cohorts.
Source: This man with ALS is "the first power user" of a brain implant that lets him speak